AMN Healthcare CFO files amended Form 4 on RSUs

AMN Healthcare Services’ CFO/COO, Brian M. Scott, filed an amended Form 4 to update his equity holdings after January 15, 2026 transactions.

Rhea-AI Filing Summary

AMN Healthcare Services’ CFO/COO, Brian M. Scott, filed an amended Form 4 to update his equity holdings after January 15, 2026 transactions. The filing shows 8,843 Restricted Stock Units vested into common stock, with 3,592 shares withheld at $19.55 per share for taxes, leaving 13,093 common shares held directly.

After these transactions, he holds 17,956 Restricted Stock Units from a 2025 grant and 40,920 Restricted Stock Units from a new January 15, 2026 grant, each unit representing one share of AMN common stock. The amendment corrects a prior overstatement, clarifying that 40,920, not 81,840, derivative securities were beneficially owned following the reported transaction.

Insider Trade Summary

8,843 shares exercised/converted

Exercise 4 txns

Insider Scott Brian M.

Role CFO/COO

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	8,843	$0.00	$0.00
Grant/Award	Restricted Stock Units	40,920	$0.00	$0.00
Exercise	Common Stock	8,843	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	3,592	$19.55	$70K

Holdings After Transaction: Restricted Stock Units — 58,876 contracts (Direct); Common Stock — 13,093 shares (Direct)

Footnotes (8)

1. F1. Common stock acquired on the vesting of Restricted Stock Units.
2. F2. Number of shares withheld for tax purposes.
3. F3. The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.
4. F4. The Restricted Stock Units set forth in this row were granted on January 15, 2025 and vest in three tranches on each of the first, second, and third anniversaries of the grant date and the grantee's provision of three periods of credited service.
5. F5. Restricted Stock Units do not have an expiration date.
6. F6. The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2025 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.
7. F7. The Restricted Stock Units set forth in this row were granted on January 15, 2026 and vest in three tranches on each of the first, second, and third anniversaries of the grant date and the grantee's provision of three periods of credited service.
8. F8. Due to an administrative error, the Form 4 filed by the reporting person on January 16, 2026, overstated the amount of derivative securities beneficially owned following the reported transaction by 40,920 shares. This Form 4 is being amended and restated to reflect that, following the reported transaction, 40,920 securities were beneficially owned by reporting person, not 81,840 as previously reported.

FAQ

What insider activity did AMN (AMN) disclose for January 15, 2026?

AMN disclosed that its CFO/COO, Brian M. Scott, had 8,843 Restricted Stock Units vest into common stock on January 15, 2026. The filing also shows shares withheld for taxes and a new grant of 40,920 Restricted Stock Units on the same date.

How many AMN common shares does the CFO/COO hold after this Form 4/A?

After the reported transactions, the CFO/COO beneficially owns 13,093 shares of AMN common stock directly. This reflects shares received from Restricted Stock Unit vesting, net of 3,592 shares withheld at $19.55 per share for tax obligations.

What Restricted Stock Unit grants are reported in this AMN Form 4/A?

The filing reports two Restricted Stock Unit positions: 17,956 units from a grant under the AMN Healthcare 2017 Equity Plan and 40,920 units from a January 15, 2026 grant under the AMN Healthcare 2025 Equity Plan, each unit convertible into one share of common stock.

How do AMN’s Restricted Stock Units for the CFO/COO vest over time?

Both the January 15, 2025 and January 15, 2026 Restricted Stock Unit grants vest in three tranches. They vest on each of the first, second, and third anniversaries of the grant date, subject to the grantee providing three periods of credited service.

Why was this AMN Form 4 amended for the CFO/COO?

The amendment corrects an administrative error in the original January 16, 2026 filing. That filing overstated derivative securities beneficially owned after the transaction by 40,920 shares; the corrected amount is 40,920, not 81,840, derivative securities beneficially owned.

Were any AMN shares sold outright by the CFO/COO in this filing?

The filing shows 3,592 AMN common shares coded as an F transaction at $19.55 per share, representing shares withheld for tax purposes. This withholding occurred in connection with the vesting of 8,843 Restricted Stock Units into common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/30/2026 - 10:54 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Scott Brian M.

(Last) (First) (Middle)

12400 HIGH BLUFF DRIVE, SUITE 500

(Street)

SAN DIEGO CA 92130

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AMN HEALTHCARE SERVICES INC [ AMN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO/COO

3. Date of Earliest Transaction (Month/Day/Year)
01/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)
01/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/15/2026		M(1)		8,843	A	$0	16,685	D
Common Stock	01/15/2026		F(2)		3,592	D	$19.55	13,093	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(3)	01/15/2026		M			8,843	(4)	(5)	Common Stock	8,843	$0	17,956	D
Restricted Stock Units	(6)	01/15/2026		A		40,920		(7)	(5)	Common Stock	40,920	$0	40,920(8)	D

Explanation of Responses:

1. Common stock acquired on the vesting of Restricted Stock Units.

2. Number of shares withheld for tax purposes.

3. The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

4. The Restricted Stock Units set forth in this row were granted on January 15, 2025 and vest in three tranches on each of the first, second, and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

5. Restricted Stock Units do not have an expiration date.

6. The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2025 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

7. The Restricted Stock Units set forth in this row were granted on January 15, 2026 and vest in three tranches on each of the first, second, and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

8. Due to an administrative error, the Form 4 filed by the reporting person on January 16, 2026, overstated the amount of derivative securities beneficially owned following the reported transaction by 40,920 shares. This Form 4 is being amended and restated to reflect that, following the reported transaction, 40,920 securities were beneficially owned by reporting person, not 81,840 as previously reported.

Remarks:

	/s/ Brian M. Scott	01/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.